164 related articles for article (PubMed ID: 30340430)
1. Perivascular Tumor-Infiltrating Leukocyte Scoring for Prognosis of Resected Hepatocellular Carcinoma Patients.
Schoenberg MB; Hao J; Bucher JN; Miksch RC; Anger HJW; Mayer B; Mayerle J; Neumann J; Guba MO; Werner J; Bazhin AV
Cancers (Basel); 2018 Oct; 10(10):. PubMed ID: 30340430
[TBL] [Abstract][Full Text] [Related]
2. Leukocytes infiltration correlates intratumoral microvessel density and influence overall and late-phase disease-free survival in hepatocellular carcinoma.
Yang Y; Fu N; Wang H; Hao J
Medicine (Baltimore); 2021 Dec; 100(48):e28135. PubMed ID: 35049245
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Impact of Tumor-Infiltrating Lymphocytes and Neutrophils on Survival of Patients with Upfront Resection of Pancreatic Cancer.
Miksch RC; Schoenberg MB; Weniger M; Bösch F; Ormanns S; Mayer B; Werner J; Bazhin AV; D'Haese JG
Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30609853
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.
Gao Q; Qiu SJ; Fan J; Zhou J; Wang XY; Xiao YS; Xu Y; Li YW; Tang ZY
J Clin Oncol; 2007 Jun; 25(18):2586-93. PubMed ID: 17577038
[TBL] [Abstract][Full Text] [Related]
5. The predictive value of tumor infiltrating leukocytes in Hepatocellular Carcinoma: A systematic review and meta-analysis.
Schoenberg MB; Li X; Li X; Han Y; Hao J; Miksch RC; Koch D; Börner N; Beger NT; Bucher JN; Schiergens TS; Guba MO; Werner J; Bazhin AV
Eur J Surg Oncol; 2021 Oct; 47(10):2561-2570. PubMed ID: 33966947
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Infiltrating Leukocyte Composition and Prognostic Power in Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas.
Hsiao YW; Chiu LT; Chen CH; Shih WL; Lu TP
Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31434354
[TBL] [Abstract][Full Text] [Related]
7. T- and B-Cells in the Inner Invasive Margin of Hepatocellular Carcinoma after Resection Associate with Favorable Prognosis.
Trailin A; Červenková L; Ambrozkiewicz F; Ali E; Kasi P; Pálek R; Hošek P; Třeška V; Daum O; Tonar Z; Liška V; Hemminki K
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158872
[TBL] [Abstract][Full Text] [Related]
8. Development of a reliable and accurate algorithm to quantify the tumor immune stroma (QTiS) across tumor types.
Miksch RC; Hao J; Schoenberg MB; Dötzer K; Schlüter F; Weniger M; Yin S; Ormanns S; D'Haese JG; Guba MO; Werner J; Mayer B; Bazhin AV
Oncotarget; 2017 Dec; 8(70):114935-114944. PubMed ID: 29383131
[TBL] [Abstract][Full Text] [Related]
9. Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients.
Ahmadvand S; Faghih Z; Montazer M; Safaei A; Mokhtari M; Jafari P; Talei AR; Tahmasebi S; Ghaderi A
Cell Oncol (Dordr); 2019 Jun; 42(3):343-356. PubMed ID: 30825183
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis.
Zhao Y; Ge X; He J; Cheng Y; Wang Z; Wang J; Sun L
World J Surg Oncol; 2019 May; 17(1):85. PubMed ID: 31118034
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.
Gabrielson A; Wu Y; Wang H; Jiang J; Kallakury B; Gatalica Z; Reddy S; Kleiner D; Fishbein T; Johnson L; Island E; Satoskar R; Banovac F; Jha R; Kachhela J; Feng P; Zhang T; Tesfaye A; Prins P; Loffredo C; Marshall J; Weiner L; Atkins M; He AR
Cancer Immunol Res; 2016 May; 4(5):419-30. PubMed ID: 26968206
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of intratumoral CD103+ tumor-infiltrating lymphocytes in pulmonary squamous cell carcinoma.
Koh J; Kim S; Kim MY; Go H; Jeon YK; Chung DH
Oncotarget; 2017 Feb; 8(8):13762-13769. PubMed ID: 28099920
[TBL] [Abstract][Full Text] [Related]
13. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
[TBL] [Abstract][Full Text] [Related]
14. The correlation and prognostic value of serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death-ligand 1 (sPD-L1) in patients with hepatocellular carcinoma.
Chang B; Huang T; Wei H; Shen L; Zhu D; He W; Chen Q; Zhang H; Li Y; Huang R; Li W; Wu P
Cancer Immunol Immunother; 2019 Mar; 68(3):353-363. PubMed ID: 30506460
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of infiltrating immune cell subtypes in invasive ductal carcinoma of the breast.
Xu Y; Lan S; Zheng Q
Tumori; 2018 Jun; 104(3):196-201. PubMed ID: 28430349
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection.
Li YW; Qiu SJ; Fan J; Zhou J; Gao Q; Xiao YS; Xu YF
J Hepatol; 2011 Mar; 54(3):497-505. PubMed ID: 21112656
[TBL] [Abstract][Full Text] [Related]
17. VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma.
Zhang M; Pang HJ; Zhao W; Li YF; Yan LX; Dong ZY; He XF
BMC Cancer; 2018 May; 18(1):511. PubMed ID: 29720116
[TBL] [Abstract][Full Text] [Related]
18. The Determination of Immunomodulation and Its Impact on Survival of Rectal Cancer Patients Depends on the Area Comprising a Tissue Microarray.
Gruber ES; Oberhuber G; Pils D; Stork T; Sinn K; Gruber S; Nica R; Kolmer D; Turner SD; Schlederer M; Widder J; Doerr W; Teleky B; Kenner L
Cancers (Basel); 2020 Feb; 12(3):. PubMed ID: 32121328
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma.
Ohno A; Yorita K; Haruyama Y; Kondo K; Kato A; Ohtomo T; Kawaguchi M; Marutuska K; Chijiiwa K; Kataoka H
Liver Int; 2014 Jul; 34(6):942-52. PubMed ID: 24433439
[TBL] [Abstract][Full Text] [Related]
20. Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer.
Matsumoto H; Thike AA; Li H; Yeong J; Koo SL; Dent RA; Tan PH; Iqbal J
Breast Cancer Res Treat; 2016 Apr; 156(2):237-47. PubMed ID: 26960711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
